-transparent.png){kind=logo}
2 patients with systemic lupus erythematosus and mild renal functional impairment were treated with ibuprofen, one of the phenylproprionic nonsteroidal anti-inflammatory drugs. Within days after the onset of therapy, both developed renal insufficiency manifested by elevated serum creatinine levels, increased proteinuria, and active urinary sediments; 1 patient was oliguric. Renal biopsies disclosed mesangial proliferative lupus glomerulonephritis and acute tubular necrosis, the latter more pronounced in the oliguric patient. Renal failure resolved following discontinuation of ibuprofen and supportive therapy. It is postulated that altered blood flow, mediated through the well-known prostaglandin synthetase inhibitory effects of ibuprofen, resulted in tubular necrosis. This undesirable complication of ibuprofen therapy may be enhanced in patients with underlying renal disease, and may be a factor governing the limitation of its usage.
H J Fong, and
A H Cohen
December 1961,
American practitioner and digest of treatment,
H J Fong, and
A H Cohen
September 1987,
Wisconsin medical journal,
H J Fong, and
A H Cohen
December 1987,
Archives of internal medicine,
H J Fong, and
A H Cohen
May 1980,
The Indian journal of medical research,
H J Fong, and
A H Cohen
July 1963,
The Medical clinics of North America,
H J Fong, and
A H Cohen
January 1997,
American journal of therapeutics,
H J Fong, and
A H Cohen
March 1960,
The New England journal of medicine,
H J Fong, and
A H Cohen
November 1976,
Arizona medicine,
H J Fong, and
A H Cohen
February 2019,
Kidney international reports,
H J Fong, and
A H Cohen
February 1968,
Revista clinica espanola,
